Deciphera Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
19.64
|
|
Average Rating
|
3.90
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
3
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.58
|
-0.55
|
0.03
|
5.17%
|
|
2022-06-30
|
-0.66
|
-0.60
|
0.06
|
9.09%
|
|
2022-03-31
|
-0.90
|
-0.80
|
0.10
|
11.11%
|
|
2021-12-31
|
-1.38
|
-1.51
|
-0.13
|
-9.42%
|
|
2021-09-30
|
-1.28
|
-1.37
|
-0.09
|
-7.03%
|
|
2021-06-30
|
-1.15
|
-1.21
|
-0.06
|
-5.22%
|
|
2021-03-31
|
-1.06
|
-1.06
|
0.00
|
0.00%
|
|
2020-12-31
|
-1.15
|
-1.10
|
0.05
|
4.35%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.95
|
|
2021-12-31
|
-5.15
|
|
2020-12-31
|
-4.79
|
|
2019-12-31
|
-4.40
|
|
2018-12-31
|
-2.82
|
|
2017-12-31
|
-6.72
|